We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

LIVE MARKETS-Europe in the red on Biden's challenges, pandemic

Fri, 15th Jan 2021 06:28

* European stock futures down 0.7%

*

Jan 15 - Welcome to the home for real-time coverage of
markets brought to you by Reuters reporters. You can share your
thoughts with us at markets.research@thomsonreuters.com

EUROPE IN THE RED ON BIDEN’S CHALLENGES, PANDEMIC

European stock futures are in the red as markets focus on
the challenges U.S. president-elect Joe Biden will face in
getting approved a $1.9 trillion stimulus package, while
pandemic concerns continue to weigh on sentiment.

Investors are also concerned about possible tax increases
they expect to be part of Biden’s future plans.

China reporting the highest number of COVID-19 cases in more
than 10 months on Friday, with more than 28 million people under
lockdown, is dampening risk-appetite across the board.

(Stefano Rebaudo)

*****

Related Shares

More News
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negoti...

29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...

29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe a...

29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.